IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
| Revenue (Most Recent Fiscal Year) | $48.67M |
| Net Income (Most Recent Fiscal Year) | $-8.91M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.44 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -10.86% |
| Net Margin (Trailing 12 Months) | -10.95% |
| Return on Equity (Trailing 12 Months) | -386.93% |
| Return on Assets (Trailing 12 Months) | -17.42% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.96 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.34 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 62.29 |
| Inventory Turnover (Trailing 12 Months) | 2.98 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.00 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.33 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 16.99M |
| Free Float | 15.73M |
| Market Capitalization | $22.09M |
| Average Volume (Last 20 Days) | 0.09M |
| Beta (Past 60 Months) | 0.62 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 7.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 20.10% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |